By Dave West and Ben Clover2011-12-07T12:00:00
Providers and commissioners face significant financial penalties if they fail to innovate in six “high impact” areas or follow National Institute for Health and Clinical Excellence guidance on drugs and best practice.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud